// App-Quantinova.ai

Tu1072 : Pre-Medication With Oral Gabapentin Is Safe and May Reduce Patient Anxiety and Post-Procedure Pain in Patients Undergoing ERCP Using Combination Benzodiazepine and Opiate Regimens for Moderate Sedation

Researchers

Presenter

  • Suzette E. Schmidt

Principal Investigators

  • Sheryl Lynch

  • Evan L. Fogel

  • James L. Watkins

  • Lee McHenry

  • Glen A. Lehman

  • Stuart Sherman

  • Gregory A. Cote

Medical Centers

  • Department of Medical Oncology, Indiana University, Indianapolis, IN

  • Department of Internal Medicine, University of Manitoba, Winnipeg, MB, Canada

Locations

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Anxiety

Biomarkers

  • N/A

Drug/Treatment

  • Gabapentin

  • Propofol

  • Opiate

Outcome

  • N/A

Study Design

  • randomized

  • double blind/blinded

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved